Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia (Q44813441)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia |
scientific article published in April 2004 |
Statements
1 reference
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia (English)
1 reference
Hagop M Kantarjian
1 reference
Srdan Verstovsek
1 reference
William G Wierda
1 reference
Guillermo Garcia-Manero
1 reference
Jorge E Cortes
1 reference
Maher Albitar
1 reference
Martin S Tallman
1 reference
Francis J Giles
1 reference
Deborah A Thomas
1 reference
Marta Hamilton
1 reference
Emma Barrett
1 reference
1 April 2004
1 reference
1 reference
100
1 reference
7
1 reference
1449-1458
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference